Uniting to Improve Colorectal Cancer Care

The Colorectal Cancer Care Initiative (CRCCI) is more than just a partnership—it’s a powerful force
dedicated to transforming colorectal cancer care. Be part of the change shaping the future of colorectal cancer
screening, diagnosis, and treatment.

Uniting to Improve Colorectal Cancer Care

The Colorectal Cancer Care Initiative (CRCCI) is more than just a partnership—it’s a powerful force dedicated to transforming colorectal cancer care. Be part of the change shaping the future of colorectal cancer screening, diagnosis, and treatment.

Ambitious Goals, Improved Outcomes

We all want better outcomes for colorectal cancer patients. Setting clear, actionable goals is essential, as what gets measured, gets done. As part of the CRCCI, we have developed a set of goals that serve as tools for health systems and the CRC community to assess progress, identify gaps, and make meaningful improvements.

Goal 1: Timely Screening for CRC Prevention Goal 2: Accurate, Informative Diagnosis and Timely Treatment Initiation
  • Achieve an 80% screening rate for average-risk patients.
  • Ensure 80% of patients with an abnormal non-invasive screening test receive a follow-up colonoscopy within 90 days (3 months).
  • Ensure 80% of patients diagnosed with CRC receive biomarker testing in accordance with NCCN Clinical Practice Guidelines (NCCN Guidelines®).
  • Ensure 80% of patients diagnosed with CRC undergo germline genetic testing at the time of diagnosis.
  • Ensure 80% of patients initiate treatment within six weeks of a CRC diagnosis.

Ambitious Goals, Improved Outcomes

We all want better outcomes for colorectal cancer patients. Setting clear, actionable goals is essential, as what gets measured, gets done. As part of the CRCCI, we have developed a set of goals that serve as tools for health systems and the CRC community to assess progress, identify gaps, and make meaningful improvements.

Goal 1: Timely Screening for CRC Prevention Goal 2: Accurate, Informative Diagnosis and Timely Treatment Initiation
  • Achieve an 80% screening rate for average-risk patients.
  • Ensure 80% of patients with an abnormal non-invasive screening test receive a follow-up colonoscopy within 90 days (3 months).
  • Ensure 80% of patients diagnosed with CRC receive biomarker testing in accordance with NCCN Clinical Practice Guidelines (NCCN Guidelines®).
  • Ensure 80% of patients diagnosed with CRC undergo germline genetic testing at the time of diagnosis.
  • Ensure 80% of patients initiate treatment within six weeks of a CRC diagnosis.

Be Part of the Change

Your involvement in CRCCI—whether as a donor, volunteer, or advocate—adds to the collective strength that drives this initiative forward. By joining the CRCCI and uniting around these goals, together we can transform colorectal cancer screening and care.

Be Part of the Change

Your involvement in CRCCI—whether as a donor, volunteer, or advocate—adds to the collective strength that drives this initiative forward. By joining the CRCCI and uniting around these goals, together we can transform colorectal cancer screening and care.

Why CRCCI Matters

In the fight against colorectal cancer, no one should face it alone. CRCCI unites an unmatched network of expertise, resources, and personal experiences to tackle the challenges of this disease head-on. From accelerating research and innovation to advocating for critical policy changes, every partnership within CRCCI strengthens our ability to change lives.

Why CRCCI Matters

In the fight against colorectal cancer, no one should face it alone. CRCCI unites an unmatched network of expertise, resources, and personal experiences to tackle the challenges of this disease head-on. From accelerating research and innovation to advocating for critical policy changes, every partnership within CRCCI strengthens our ability to change lives.

About the Report

The Colorectal Cancer Care Report is the first major effort of the CRCCI and a response to a critical gap in colorectal cancer care. We are not effectively measuring the quality of care received in the U.S. Real-world patient data provides incredible insights, but when it is not effectively utilized to inform healthcare decisions, disparities in care and outcomes persist. This leads to suboptimal screening strategies, delayed diagnoses, and inconsistent treatment approaches, particularly for younger demographics who are increasingly at risk.

This report establishes clear, actionable goals for colorectal cancer screening and care that stakeholders across the colorectal cancer community can rally around. It serves as a tool to help healthcare systems nationwide leverage data to measure progress, allocate resources, and improve outcomes.

About the Report

The Colorectal Cancer Care Report is the first major effort of the CRCCI and a response to a critical gap in colorectal cancer care. We are not effectively measuring the quality of care received in the U.S. Real-world patient data provides incredible insights, but when it is not effectively utilized to inform healthcare decisions, disparities in care and outcomes persist. This leads to suboptimal screening strategies, delayed diagnoses, and inconsistent treatment approaches, particularly for younger demographics who are increasingly at risk.

This report establishes clear, actionable goals for colorectal cancer screening and care that stakeholders across the colorectal cancer community can rally around. It serves as a tool to help healthcare systems nationwide leverage data to measure progress, allocate resources, and improve outcomes.

Thank You Program Sponsors

gold

bronze